← Oct 20 · Tue, Oct 20

OpenAI acquires Orchestra Bio

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

At a glance

  • openai.com: OpenAI acquires Orchestra Bio
  • techmeme.com: OpenAI acquires Orchestra Bio, which builds AI agents for managing drug development, and plans to integrate its tech into OpenAI life sciences suite Rosalind (Madison Mills/Axios)

The story

openai.com: OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

techmeme.com: Madison Mills / Axios : OpenAI acquires Orchestra Bio, which builds AI agents for managing drug development, and plans to integrate its tech into OpenAI life sciences suite Rosalind OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, the ChatGPT maker shared exclusively with Axios.

Get tomorrow's scan at 7am

The same ranked list, in your inbox. Nothing else, ever.

← Back to Oct 20